x 

0 Activities
0 Activities
    • No Saved Activities
Page 3 of 4
Results 301 - 450 of 482
No image set
Diabetes: Successful Co-management between Primary Care and Endocrinology
No image set
Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Vector Gene Transfer
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
No image set
Understanding the Endocannabinoid System (Cystic Fibrosis)
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
No image set
COPD: Proper Inhaler Use
No image set
Gene Therapy for Treatment of Hemophilia: Other Strategies and Targets
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
castro-tff
Updates in SMA from Austin, Texas
No image set
Technology Improving SMA Patients’ Quality of Life
No image set
Nusinersen Treatment Outcomes in Later-Onset SMA
No image set
Patients with Severe SMA Need Additional Respiratory Management
Castro_02
Clear Expectations Needed in SMA Patient Management
Castro_01
Improvements in Quality of Life for Patients with Neuromuscular Diseases
9927-264x150
Updates in SMA and Gene Therapy from Copenhagen, Denmark
9920-264x150
The Changing Landscape of SMA–Updates from Copenhagen, Denmark
No image set
Pulmonologists as the Gatekeepers of Precision Medicine
9915-conf_covg_icon_263x149
Conference Coverage from ISTH 2019 in Melbourne
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
No image set
How to Identify & Manage Patients with Progressive-Fibrosing ILD
No image set
A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting
9915-mod3-icon
A History of Hemophilia Treatment: Non-replacement Therapy to Gene Therapy
No image set
Gene Therapy for Treatment of Hemophilia: Common Concerns in Gene Therapy
9916-cme-icon
Personalized Medicine for Improving Asthma Care: An Animated Video Series
9815-developments
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9815-palliative slides
Palliative Medicine in Pulmonology
No image set
Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation
No image set
Dyspnea and Disease are Progressing: What to Do?
No image set
Thoracic Radiology
No image set
A Closer Look at ILD, Sarcoidosis, and CTEPH
No image set
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9916-0005-icon
Discussions with Patients to Optimize Asthma Control
9916-0004_treatment
Who Should be Targeted For Treatment With Biologic Therapy?
9916-0003_endotypes
Endotypes and Phenotypes in Asthma
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9916-0001_meds
Approved Medications for the Treatment of Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
9830-icon1
Atopic Dermatitis: Diagnosis and Management in Infants and Children
9830-icon2
Updates in Atopic Dermatitis: Diagnosis and Management in Adults
sma-icon
Are You Ready for Gene Replacement Therapy?
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9915-mod2-icon
A History of Hemophilia Treatment: Factor Replacement to Gene Therapy
9915-mod1-icon
Getting to Know Gene Therapy: Terminology and Concepts
New_Concepts_in_the_Pathobiology_of_Asthma_264x150
New Concepts in the Pathobiology of Asthma
No image set
When Is a Cough Not Just a Cough?
No image set
Diagnosing ILDs Such as IPF and More
No image set
Beyond the Basics: Complex ILD Cases
No image set
PowerPoint Slides: Achieving Better Control of Severe Asthma
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult
No image set
U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine
9833-0001-icon
Urgency for Early Diagnosis and Treatment of SMA
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
No image set
Reporting HRCT Findings for ILD from a Multidisciplinary Team
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
9816-0009
The Importance of Early Integration of Palliative Care
rePlace2
Emerging Treatments for NTM Lung Disease
rePlace2
Nontuberculous Mycobacteria Case 2: Alan
rePlace2
Treatment Challenges with MAC Lung Disease
rePlace2
Nontuberculous Mycobacteria: Summary
rePlace2
Treatment Challenges with MABC Lung Disease
rePlace2
Nontuberculous Mycobacteria Case 1: Maria
rePlace2
NTM – To Treat or Not to Treat
rePlace2
Goals of NTM Treatment
rePlace2
Guideline-recommended Treatments for NTM
rePlace2
Diagnosis of NTM
rePlace2
Factors Associated with Respiratory Involvement in NTM
rePlace2
Most Common Species in NTM Lung Disease
rePlace2
Nontuberculous Mycobacteria: Introduction and Epidemiology
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
No image set
New Therapies, New Opportunities and New Challenges in Managing NTM
No image set
Updates in Inoperable CTEPH
9808-0003
SMA Updates from Los Angeles
No image set
Achieving Better Control of Severe Asthma
9808-0002
Updates in SMA and Gene Therapy from Arlington, VA
Proper_Use_of_an_Inhaler_264x150
Proper Use of an Inhaler
biosims-gastro2
Biosimilars and Patients with Inflammatory Bowel Disease
No image set
Nontuberculous Mycobacterial Lung Disease Today and Tomorrow
No image set
Exploring the Patient Journey with Problem-Based Learning
No image set
Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
No image set
Environmental Influences on the Development of Pulmonary Fibrosis
No image set
Gene Abnormalities and ILD
No image set
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
No image set
Updates on Registry Enrollment and Growth of the Care Center Network
No image set
New Approaches to the Diagnosis of IPF
No image set
Exploring New Therapeutic Avenues for Managing PF
No image set
New Research on Mechanisms in the Development of PF
biosims-gastro1
Biosimilars: The New Era of Gastroenterology Management Considerations
No image set
Know Before You Go: IPF Grand Rounds Pre-learning
No image set
IPF Management Considerations
No image set
Perspectives on Side Effect Management
No image set
The Latest in IPF: Implications for Clinical Practice
No image set
Registry Data Provide Important Severity Indicators for PH
No image set
New Developments in the Diagnosis and Management of IPF
No image set
Palliative Care for Patients with IPF
No image set
Real World Experience in Patients with COPD
No image set
ICD-10 Codes and Nomenclature for Classification of PAH
No image set
Fleischner Society Update in Classification of IPF
No image set
Transbronchial Cryobiopsy for the Diagnosis of ILD
psoriasis-nurse
Psoriasis Management Considerations: What Would You Do?
psoriasis-case3
Jamie Develops Complications with Her Psoriasis
psoriasis-case2
Psoriasis: Three Case Studies in the Primary Care Setting
psoriasis-case1
Cindy Has a Complex Case of Psoriasis
No image set
Optimizing Patient Outcomes in IPF
No image set
Understanding IPF as a Part of the Overall Scope of ILD
9707-ella
Famous People with Diabetes: Ella Fitzgerald
9707-jerry
Famous People with Diabetes: Jerry Garcia
aims icon-target
Targeting B-cells in Primary Progressive MS (PPMS)
aims icon-comorb
Comorbidities and Selection of DMTs
aims icon-gut
The Gut Microbiota in MS
aims icon-early
Early MS: Induction Therapy and Escalation Strategies
aims icon-vitamin
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
t2diabetes-slides1
Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options
No image set
The Importance of Early Referral and Treatment
No image set
How to Recognize and Diagnose IPF
No image set
What Is IPF?
No image set
What’s Next for IPF Therapy?
No image set
Applying the Evidence on Antifibrotic Agents for IPF
No image set
What Do the Experts Say about New Developments in the Diagnosis of ILD?
No image set
Is the delivery system a good match for your patients with COPD?
No image set
Stepping up or stepping down – which direction for COPD patients?
No image set
What’s the 2017 GOLD standard for managing patients with COPD?
No image set
UIP, IPF, NSIP, CHP: Making Sense of the Letters
t2diabetes-slides2
Download Slides: Advancing T2DM Therapy with Confidence
t2diabetes-louise
Getting to Goal Can Be Difficult: Louise
t2diabetes-brian
Getting to Goal Can Be Difficult: Brian
No image set
A Personalized Approach to Managing Patients with Uncontrolled Asthma
IL-rheum-case3
Considering Biosimilars in Patients Failing their Initial Biologic
IL-rheum-case2
When to Switch? Biologically Experienced Patients with Spondyloarthritis
IL-rheum-case1
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
IL-gastro-case3
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
Page 3 of 4

Search